Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).

Trial Profile

Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Aug 2014

At a glance

  • Drugs Ivabradine (Primary) ; Carvedilol
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms CARVIVA HF
  • Most Recent Events

    • 18 Aug 2014 Results published in Medicographia.
    • 29 Sep 2011 New trial record
    • 01 Sep 2011 Results published in the International Journal of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top